Importance of the Lipid Layer in Human Tear Film Stability and Evaporation

Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film...

Full description

Saved in:
Bibliographic Details
Published inOptometry and vision science Vol. 74; no. 1; pp. 8 - 13
Main Authors CRAIG, JENNIFER P., TOMLINSON, ALAN
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.01.1997
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals. The left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment. Tear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability. Where the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded.
AbstractList Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals.PURPOSEPrevious work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals.The left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment.METHODSThe left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment.Tear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability.RESULTSTear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability.Where the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded.CONCLUSIONSWhere the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded.
Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals. The left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment. Tear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability. Where the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded.
Purpose. Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals. Methods. The left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment. Results. Tear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability. Conclusions. Where the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded.
Author TOMLINSON, ALAN
CRAIG, JENNIFER P.
Author_xml – sequence: 1
  givenname: JENNIFER P.
  surname: CRAIG
  fullname: CRAIG, JENNIFER P.
– sequence: 2
  givenname: ALAN
  surname: TOMLINSON
  fullname: TOMLINSON, ALAN
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2613866$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9148269$$D View this record in MEDLINE/PubMed
BookMark eNqFkTtPwzAUhT0UlVL4CUgeEFvAThw_FiRUtbSoEgNljm4SRxjlUWwHqf8etw0dWGrJsnzvd85wzhUatV2rEcKUPFCixCMJhycxi6hSgtDwi8KlbIQmlDASpUzKS3Tl3FeYiiTlYzRWlMmYqwl6XTXbznpoC427CvtPjddma0q8hp222LR42TfQ4o0GixembvC7h9zUxu8wtCWe_0DQgzdde40uKqidvhneKfpYzDezZbR-e1nNntdRwRLuI0iFTlmec6GFZKLSMaOylKrKc5HSMqa0EFKVoopFyZSGRCQECOMUwjBRVTJF90ffre2-e-181hhX6LqGVne9y4SUkgiengUpJ0SImAfwdgD7vNFltrWmAbvLhpTC_m7YgyugrmyIy7gTFnOaSL63kUessJ1zVlcngpJsX1X2V1V2qio7VBWkT_-khfGHVL0FU583-AV7SZiF
CODEN OVSCET
CitedBy_id crossref_primary_10_1016_j_clae_2010_02_003
crossref_primary_10_1080_02713680902972366
crossref_primary_10_1016_j_clae_2005_06_001
crossref_primary_10_1016_j_optom_2018_01_004
crossref_primary_10_1016_j_clae_2009_06_004
crossref_primary_10_1111_cxo_12546
crossref_primary_10_1136_bjophthalmol_2019_315747
crossref_primary_10_1016_j_pquantelec_2018_10_001
crossref_primary_10_1111_ceo_12135
crossref_primary_10_1097_OPX_0b013e318253de93
crossref_primary_10_1016_S1542_0124_12_70262_8
crossref_primary_10_1039_C6LC01450J
crossref_primary_10_1097_OPX_0b013e318181ae60
crossref_primary_10_1016_j_exer_2013_08_010
crossref_primary_10_4103_IJO_IJO_2851_22
crossref_primary_10_1155_2019_8127515
crossref_primary_10_1007_s10792_020_01300_z
crossref_primary_10_1097_ICO_0000000000000092
crossref_primary_10_1097_ICO_0000000000001181
crossref_primary_10_1016_j_clae_2022_101705
crossref_primary_10_1080_02713683_2022_2093381
crossref_primary_10_1007_s00417_015_3080_5
crossref_primary_10_1016_j_preteyeres_2004_04_003
crossref_primary_10_1371_journal_pone_0092461
crossref_primary_10_1097_01_ICL_0000141921_80061_17
crossref_primary_10_12968_opti_2016_2_109
crossref_primary_10_1016_j_clae_2014_09_007
crossref_primary_10_1016_j_jtos_2019_11_004
crossref_primary_10_1016_j_oftal_2022_03_008
crossref_primary_10_1016_S1542_0124_12_70081_2
crossref_primary_10_1097_OPX_0b013e3181d951df
crossref_primary_10_1097_00006324_200206000_00009
crossref_primary_10_3390_diagnostics10080511
crossref_primary_10_1016_j_clae_2017_12_003
crossref_primary_10_1097_ICO_0000000000000660
crossref_primary_10_15406_aovs_2015_02_00038
crossref_primary_10_1016_j_jtos_2018_09_005
crossref_primary_10_1016_j_tvjl_2006_10_008
crossref_primary_10_1016_j_clae_2017_07_003
crossref_primary_10_1007_s00417_006_0452_x
crossref_primary_10_1146_annurev_fluid_120710_101042
crossref_primary_10_1016_j_clim_2017_04_017
crossref_primary_10_1097_ICL_0b013e3181a9d79d
crossref_primary_10_1097_ICL_0000000000000103
crossref_primary_10_1111_aos_12012
crossref_primary_10_1016_j_clae_2021_02_009
crossref_primary_10_1167_iovs_64_1_13
crossref_primary_10_1002_bip_20798
crossref_primary_10_1016_j_jtos_2014_01_004
crossref_primary_10_1016_j_clae_2021_01_004
crossref_primary_10_1210_jcem_85_12_7066
crossref_primary_10_1007_s11538_012_9746_9
crossref_primary_10_3109_02713683_2010_490895
crossref_primary_10_1002_jbm_b_32927
crossref_primary_10_1016_j_exer_2013_05_010
crossref_primary_10_1016_S0161_6420_03_00451_2
crossref_primary_10_1080_17469899_2023_2258279
crossref_primary_10_3341_jkos_2020_61_1_1
crossref_primary_10_3390_ijms232314947
crossref_primary_10_1016_S0014_4835_03_00199_4
crossref_primary_10_1111_j_1444_0938_2011_00634_x
crossref_primary_10_1097_OPX_0000000000001680
crossref_primary_10_1016_j_jtos_2021_04_006
crossref_primary_10_1097_01_ico_0000148291_38076_59
crossref_primary_10_1046_j_1475_1313_2002_00042_x
crossref_primary_10_1016_j_jtos_2019_03_004
crossref_primary_10_1080_09273948_2019_1571212
crossref_primary_10_1016_j_clae_2012_05_003
crossref_primary_10_1097_ICL_0b013e31828af164
crossref_primary_10_18621_eurj_558779
crossref_primary_10_1097_01_icl_0000240501_07041_f8
crossref_primary_10_1016_S1367_0484_00_80024_7
crossref_primary_10_1097_ICO_0b013e31824d0d04
crossref_primary_10_1097_00003226_200308000_00006
crossref_primary_10_1007_s00717_020_00475_1
crossref_primary_10_1021_acs_langmuir_9b01114
crossref_primary_10_1111_j_1444_0938_2007_00136_x
crossref_primary_10_1016_j_clae_2017_01_004
crossref_primary_10_1016_j_jtos_2021_10_009
crossref_primary_10_1136_bmjophth_2020_000697
crossref_primary_10_1016_j_oftale_2022_03_015
crossref_primary_10_1118_1_3495540
crossref_primary_10_3390_medicina60091458
crossref_primary_10_1097_ICO_0b013e31802b492d
crossref_primary_10_1097_OPX_0b013e31826f32e0
crossref_primary_10_1016_j_aanat_2015_07_007
crossref_primary_10_1097_OPX_0b013e3181c07908
crossref_primary_10_1155_2015_704946
crossref_primary_10_1155_2016_7285132
crossref_primary_10_1016_j_jprot_2012_11_017
crossref_primary_10_1016_S1367_0484_98_80035_0
crossref_primary_10_1155_2016_5728071
crossref_primary_10_1097_01_opx_0000236810_17338_cf
crossref_primary_10_1080_02713683_2018_1554154
crossref_primary_10_1016_j_jtos_2020_12_006
crossref_primary_10_1016_j_clae_2003_09_002
crossref_primary_10_1080_02713683_2018_1433860
crossref_primary_10_1016_j_clae_2019_08_003
crossref_primary_10_18231_j_ijceo_2020_023
crossref_primary_10_2147_OPTO_S262353
crossref_primary_10_1016_j_jtos_2013_04_004
crossref_primary_10_1016_S1542_0124_11_70009_X
crossref_primary_10_1186_s12938_018_0597_y
crossref_primary_10_1016_j_chemphyslip_2007_04_001
crossref_primary_10_1016_j_envint_2008_04_005
crossref_primary_10_1021_acs_joc_0c02882
crossref_primary_10_1038_s41598_020_71259_5
crossref_primary_10_1076_ceyr_25_4_227_13482
crossref_primary_10_1016_j_clae_2019_11_009
crossref_primary_10_1364_OL_44_002410
crossref_primary_10_1021_acs_langmuir_8b04182
crossref_primary_10_1016_j_colsurfb_2019_04_051
crossref_primary_10_1016_j_clae_2010_03_002
crossref_primary_10_1016_j_optom_2019_09_002
crossref_primary_10_1016_j_apm_2014_05_006
crossref_primary_10_1021_la501678t
crossref_primary_10_1111_opo_13308
crossref_primary_10_1016_j_clae_2022_101736
crossref_primary_10_1155_2014_848659
crossref_primary_10_1097_ICL_0000000000000788
crossref_primary_10_18231_j_ijceo_2020_030
crossref_primary_10_1097_01_opx_0000171818_01353_8c
crossref_primary_10_1016_j_clae_2015_06_002
crossref_primary_10_5301_ejo_5000277
crossref_primary_10_1016_j_clinthera_2015_01_001
crossref_primary_10_1016_S0181_5512_06_73800_1
crossref_primary_10_1080_02713683_2017_1418894
crossref_primary_10_1097_OPX_0000000000000827
crossref_primary_10_1097_ICO_0000000000002133
crossref_primary_10_19161_etd_416656
crossref_primary_10_1016_j_clae_2021_101560
crossref_primary_10_3390_ijms24086983
crossref_primary_10_3928_1081_597X_20010101_02
crossref_primary_10_1016_j_jfo_2018_10_004
crossref_primary_10_1016_j_exer_2022_109061
crossref_primary_10_3390_pharmaceutics13020207
crossref_primary_10_1097_OPX_0b013e318181ae02
crossref_primary_10_1017_jfm_2018_776
crossref_primary_10_1016_j_clae_2019_04_003
crossref_primary_10_1016_S1542_0124_12_70186_6
crossref_primary_10_1016_j_clae_2009_12_007
crossref_primary_10_1172_jci_insight_151078
crossref_primary_10_3390_medicina59101862
crossref_primary_10_1097_ICO_0b013e3181ba0cb2
crossref_primary_10_1167_iovs_18_26390
crossref_primary_10_2174_2210681213666230526152322
crossref_primary_10_1016_j_clae_2014_05_008
crossref_primary_10_1016_j_exer_2009_11_013
crossref_primary_10_1038_s41598_021_94568_9
crossref_primary_10_12677_HJO_2023_121008
crossref_primary_10_1097_00006324_200002000_00010
crossref_primary_10_3390_jcm13051220
crossref_primary_10_1016_j_jtos_2020_01_003
crossref_primary_10_1016_j_preteyeres_2021_101012
crossref_primary_10_2147_OPTH_S270575
crossref_primary_10_1007_s00417_020_05044_5
crossref_primary_10_1016_j_clae_2013_02_009
crossref_primary_10_1016_j_jtos_2022_01_002
crossref_primary_10_1080_01647954_2021_1919757
crossref_primary_10_1016_j_jfo_2018_08_017
crossref_primary_10_1016_j_jtos_2012_07_004
crossref_primary_10_1016_j_biopha_2025_117937
crossref_primary_10_1016_j_jtos_2017_05_006
crossref_primary_10_1007_s40123_022_00518_7
crossref_primary_10_1080_02713683_2018_1437454
crossref_primary_10_17116_oftalma202313903281
crossref_primary_10_1016_j_jtos_2017_05_001
crossref_primary_10_1016_j_clae_2019_09_004
crossref_primary_10_1016_j_jtos_2021_03_006
crossref_primary_10_1016_S1542_0124_11_70033_7
crossref_primary_10_3341_kjo_2019_0133
crossref_primary_10_3928_1081597X_20200519_01
crossref_primary_10_1097_ICL_0000000000000073
crossref_primary_10_1529_biophysj_105_078592
crossref_primary_10_1167_tvst_8_5_1
crossref_primary_10_1089_jop_2017_0052
crossref_primary_10_1097_ICL_0b013e31822e8df2
crossref_primary_10_3390_ijms18071398
crossref_primary_10_1097_OPX_0b013e3181bc63cc
crossref_primary_10_1016_j_jtos_2016_03_002
crossref_primary_10_1016_j_jtos_2018_03_002
crossref_primary_10_3389_ftox_2023_1173683
crossref_primary_10_1016_j_clae_2025_102369
crossref_primary_10_1097_00006324_200403000_00012
crossref_primary_10_1007_s11538_006_9105_9
crossref_primary_10_1371_journal_pone_0109843
crossref_primary_10_1016_j_jtos_2017_05_011
crossref_primary_10_1097_ICO_0b013e318191b870
crossref_primary_10_1016_j_exer_2021_108567
crossref_primary_10_1088_1742_6596_1073_6_062034
crossref_primary_10_1021_acs_jpclett_9b01187
crossref_primary_10_3390_jcm12206631
crossref_primary_10_3389_fmed_2021_781382
crossref_primary_10_3390_colloids5020030
crossref_primary_10_1186_s12917_019_2203_3
crossref_primary_10_26599_FRICT_2025_9441014
crossref_primary_10_1016_j_addr_2023_115004
crossref_primary_10_1097_OPX_0000000000000601
crossref_primary_10_3390_diagnostics10090711
crossref_primary_10_1007_s11538_018_0517_0
crossref_primary_10_5005_hoo_10101_39402
crossref_primary_10_1016_j_ajo_2007_04_006
crossref_primary_10_1097_OPX_0000000000001136
crossref_primary_10_3109_02713683_2011_574331
crossref_primary_10_1016_j_exer_2012_04_003
crossref_primary_10_1097_OPX_0000000000002225
crossref_primary_10_1038_sj_eye_6700224
crossref_primary_10_1097_ICO_0b013e31826671ab
crossref_primary_10_3390_diagnostics12061431
crossref_primary_10_1097_OPX_0b013e318253dea9
crossref_primary_10_1016_j_cis_2013_03_007
crossref_primary_10_1016_j_exer_2010_05_014
crossref_primary_10_1186_s12886_018_0700_y
crossref_primary_10_3341_jkos_2016_57_12_1857
crossref_primary_10_1080_08820538_2020_1755321
crossref_primary_10_1016_j_ajo_2013_01_008
crossref_primary_10_1016_j_preteyeres_2014_11_001
crossref_primary_10_1016_j_exer_2017_03_013
crossref_primary_10_1097_ICO_0000000000000393
crossref_primary_10_1016_j_addr_2017_09_023
crossref_primary_10_1080_02713680490516099
crossref_primary_10_1111_j_1469_7580_2005_00386_x
crossref_primary_10_1167_iovs_17_23700
crossref_primary_10_1080_14656566_2025_2450360
crossref_primary_10_2147_OPTH_S322461
crossref_primary_10_1016_j_jtos_2023_07_002
crossref_primary_10_1016_j_jtos_2023_07_004
crossref_primary_10_1016_j_bbamem_2014_05_007
crossref_primary_10_1016_j_actbio_2021_05_051
crossref_primary_10_1016_S1542_0124_12_70086_1
crossref_primary_10_1111_j_1749_6632_2002_tb04217_x
crossref_primary_10_1016_j_clae_2018_12_002
crossref_primary_10_1016_j_clae_2017_09_004
crossref_primary_10_1364_OSAC_1_001041
crossref_primary_10_1016_j_ajo_2013_01_017
crossref_primary_10_1016_j_clae_2007_12_001
crossref_primary_10_1016_j_exer_2023_109557
crossref_primary_10_1016_j_exer_2017_03_006
crossref_primary_10_1097_ICO_0000000000001377
crossref_primary_10_1097_OPX_0000000000000749
crossref_primary_10_1016_j_cis_2015_12_009
crossref_primary_10_1016_j_clae_2017_09_013
crossref_primary_10_1016_S1542_0124_12_70233_1
crossref_primary_10_1021_bm100655j
crossref_primary_10_1097_OPX_0000000000000866
crossref_primary_10_1097_OPX_0000000000001156
crossref_primary_10_1016_j_clae_2016_11_002
crossref_primary_10_1016_S1542_0124_12_70150_7
crossref_primary_10_1016_j_jtos_2021_10_003
crossref_primary_10_1097_OPX_0000000000002000
crossref_primary_10_1016_j_jtos_2014_06_002
crossref_primary_10_1016_j_jtos_2018_06_001
crossref_primary_10_1016_j_ajo_2022_02_010
crossref_primary_10_1016_j_jtos_2021_12_011
crossref_primary_10_1016_j_optom_2012_10_001
crossref_primary_10_1371_journal_pone_0270810
crossref_primary_10_1016_S1542_0124_12_70095_2
crossref_primary_10_1136_bmjophth_2020_000614
crossref_primary_10_1097_ICO_0b013e318197ec24
crossref_primary_10_1111_vop_12033
crossref_primary_10_1016_S0181_5512_07_89584_2
crossref_primary_10_1016_j_exer_2006_02_002
crossref_primary_10_1097_ICL_0b013e318193f4fc
crossref_primary_10_1002_14651858_CD009729_pub2
crossref_primary_10_1016_j_bbamem_2016_02_020
crossref_primary_10_1016_j_clae_2024_102154
crossref_primary_10_1097_ICO_0000000000000452
crossref_primary_10_1016_S1542_0124_12_70299_9
crossref_primary_10_1016_j_cis_2013_06_001
crossref_primary_10_1016_j_jtos_2018_12_003
crossref_primary_10_1097_ICL_0b013e31818c5d00
crossref_primary_10_1016_j_ajo_2006_03_022
crossref_primary_10_1016_j_jtos_2012_08_001
crossref_primary_10_1038_s41598_017_17536_2
crossref_primary_10_1097_OPX_0000000000000098
crossref_primary_10_1097_01_ico_0000247219_18295_5e
crossref_primary_10_1016_j_clae_2020_04_003
crossref_primary_10_1016_j_pain_2014_04_025
crossref_primary_10_1117_1_2209881
crossref_primary_10_1016_j_jcis_2022_06_032
crossref_primary_10_1111_cxo_12597
crossref_primary_10_1021_acsbiomaterials_2c00182
crossref_primary_10_7717_peerj_18258
crossref_primary_10_1006_clim_2001_5128
crossref_primary_10_1016_j_clae_2020_03_014
crossref_primary_10_1016_j_jtos_2014_02_002
crossref_primary_10_1080_09273948_2021_1905856
crossref_primary_10_1097_OPX_0b013e3181d951b2
crossref_primary_10_1007_s00417_021_05162_8
crossref_primary_10_1016_j_clae_2019_06_004
crossref_primary_10_1016_j_clae_2019_06_001
crossref_primary_10_1097_OPX_0000000000001852
crossref_primary_10_1016_j_jtos_2019_06_003
crossref_primary_10_1371_journal_pone_0135629
crossref_primary_10_1097_01_icl_0000247638_50568_c0
crossref_primary_10_1016_j_procs_2016_05_296
crossref_primary_10_1021_ie5030497
crossref_primary_10_1016_j_clae_2014_07_006
crossref_primary_10_53730_ijhs_v8nS1_15117
crossref_primary_10_1016_j_clae_2024_102257
crossref_primary_10_1016_j_preteyeres_2017_02_002
crossref_primary_10_1016_j_clae_2019_07_008
crossref_primary_10_1016_j_exer_2014_01_007
crossref_primary_10_1167_tvst_10_14_6
crossref_primary_10_1007_s10384_018_00645_4
crossref_primary_10_2220_biomedres_34_215
crossref_primary_10_3928_1081_597X_20070301_13
crossref_primary_10_1021_la1051172
crossref_primary_10_1111_j_1600_0668_2006_00429_x
crossref_primary_10_1016_j_clae_2022_101809
crossref_primary_10_1016_j_jtos_2019_02_010
crossref_primary_10_1016_S1542_0124_12_70167_2
crossref_primary_10_1093_imammb_dqx021
crossref_primary_10_1167_iovs_62_9_13
crossref_primary_10_1016_j_clae_2017_03_001
crossref_primary_10_1070_QEL17213
crossref_primary_10_1016_S1542_0124_12_70157_X
crossref_primary_10_1097_IIO_0b013e31822d6af1
crossref_primary_10_1016_j_jtos_2017_03_006
crossref_primary_10_1016_j_survophthal_2021_04_009
crossref_primary_10_1016_j_clae_2024_102129
crossref_primary_10_1136_oem_2004_016030
crossref_primary_10_3892_etm_2017_4364
crossref_primary_10_1111_opo_13373
crossref_primary_10_1016_j_clae_2005_12_006
crossref_primary_10_1016_j_colsurfb_2020_111392
crossref_primary_10_1007_s10762_018_0497_z
crossref_primary_10_1038_eye_2000_156
crossref_primary_10_1016_j_jfo_2022_03_004
crossref_primary_10_1097_OPX_0000000000000420
crossref_primary_10_1097_OPX_0b013e31821cc683
crossref_primary_10_1016_j_jtos_2021_05_009
crossref_primary_10_1097_ICO_0b013e31821b71e6
crossref_primary_10_3341_jkos_2017_58_7_788
crossref_primary_10_1016_j_clae_2018_11_002
crossref_primary_10_1016_S0181_5512_07_89605_7
crossref_primary_10_1016_j_clae_2019_02_001
crossref_primary_10_1016_j_colsurfb_2005_05_011
crossref_primary_10_3390_pharmaceutics14071493
crossref_primary_10_1016_j_jfo_2018_12_001
crossref_primary_10_1016_j_jtos_2016_06_002
crossref_primary_10_1038_sj_eye_6701611
ContentType Journal Article
Copyright 1997 INIST-CNRS
Copyright_xml – notice: 1997 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
P64
7X8
DOI 10.1097/00006324-199701000-00014
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Engineering Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 13
ExternalDocumentID 9148269
2613866
10_1097_00006324_199701000_00014
Genre Journal Article
Comparative Study
GroupedDBID ---
-~X
.GJ
.Z2
0R~
123
4Q1
4Q2
4Q3
53G
5VS
71W
AAAAV
AAHPQ
AAIQE
AAMTA
AARTV
AASCR
AAWTL
AAYXX
ABASU
ABBUW
ABDIG
ABDPE
ABJNI
ABPXF
ABVCZ
ABXRP
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACNCT
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AEETU
AENEX
AFBFQ
AFDTB
AFFNX
AFUWQ
AHQNM
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BQLVK
BS7
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
EBS
EEVPB
EJD
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
JF9
JG8
JK3
JK8
K8S
KD2
L-C
N~M
O9-
OAG
OAH
OCUKA
ODA
OK1
OLG
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
P6G
R58
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
WH7
WOQ
WOW
X3V
X3W
XOL
XXN
XYM
YFH
ZB8
ZFV
ZXP
ZZMQN
IQODW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OLW
7QO
8FD
FR3
P64
7X8
ID FETCH-LOGICAL-c436t-a57e54bb67e7847fe2418d89fbb751d211c789d7f27d49ea3730a0461a9d739f3
ISSN 1040-5488
IngestDate Thu Jul 10 23:11:14 EDT 2025
Fri Jul 11 00:24:32 EDT 2025
Wed Feb 19 02:36:04 EST 2025
Fri May 23 02:31:14 EDT 2025
Tue Jul 01 01:35:31 EDT 2025
Thu Apr 24 22:56:53 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Tear film
Human
Visual system
Stability
Tear
Lipids
Physiology
Evaporation
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c436t-a57e54bb67e7847fe2418d89fbb751d211c789d7f27d49ea3730a0461a9d739f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 9148269
PQID 16007726
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_78880765
proquest_miscellaneous_16007726
pubmed_primary_9148269
pascalfrancis_primary_2613866
crossref_primary_10_1097_00006324_199701000_00014
crossref_citationtrail_10_1097_00006324_199701000_00014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1997-01-00
1997
1997-Jan
19970101
PublicationDateYYYYMMDD 1997-01-01
PublicationDate_xml – month: 01
  year: 1997
  text: 1997-01-00
PublicationDecade 1990
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Optometry and vision science
PublicationTitleAlternate Optom Vis Sci
PublicationYear 1997
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
SSID ssj0017356
Score 2.007872
Snippet Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested...
Purpose. Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 8
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Eye and associated structures. Visual pathways and centers. Vision
Female
Fundamental and applied biological sciences. Psychology
Humans
Lacrimal Apparatus - physiology
Lipids - physiology
Male
Middle Aged
Tears - physiology
Vertebrates: nervous system and sense organs
Volatilization
Title Importance of the Lipid Layer in Human Tear Film Stability and Evaporation
URI https://www.ncbi.nlm.nih.gov/pubmed/9148269
https://www.proquest.com/docview/16007726
https://www.proquest.com/docview/78880765
Volume 74
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZB2Mwxr5K062bHvZWXGJLlqzHsg-arElgS6FvRrZkCCSOaZ099K_f6SOKs2VbtxcTjGUH3U-nu9Pd7xB6TxKiwJMQEZeKRTQrVCTjkkZMJjFLSaG0ra0aT9jFFR1dp9e93mUna2ndFmfl3d66kv-RKtwDuZoq2X-QbHgp3IDfIF-4goThei8ZD5fWejZr0x_1L-bNXJ0uJBjSJpLhOvCZlF1DwLQ0gQObDOtIl_R32XgEdG3UadOulrq9cQ-54vNTv1OGI4uv50Nb7DQ621aIzabjy-Hk23SyjZEqX2DHt5GEPYwQNpIwX5h0nY6SNFmI4OlkXS3qeu3soMWpxKyzt7qy01-0tmMDtlsn2Hc292UQ-5J3V2K6S5T90wYW0grBGyQZYw_QwwScBqOmPw6_hDMlTmwv3_DvfV7XhsJz36d3jJUnjbyFdVO5hie_90isZTJ7hp56lwKfO3w8Rz1dv0CPxj5p4iUabWGCVxUGmGALE2xhguc1tjDBBibYwAQHmGBAAO7A5BW6-vxp9uEi8i00opIS1kYy5TqlRcG45mCHVBoMtkxloioKnsawSuOSZ0LxKuGKCi0JKHxpOPgl3CSiIofooF7V-gjhgkohdJXIkg-ookxUpWFRUAPNlcxU1Ud8M1d56fnlTZuTRd7Jc7CznIdZtqkPtI_iMLJxHCv3GHOyI44w0GOgj95txJODwjSnYLLWq_VtHpuODDz5wxMmKjTgLO2jQyfX8HJhWHOZOP7Lx1-jx47l2ETq3qCD9matT8B2bYu3FpI_AC2jk0w
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Importance+of+the+lipid+layer+in+human+tear+film+stability+and+evaporation&rft.jtitle=Optometry+and+vision+science&rft.au=CRAIG%2C+J.+P&rft.au=TOMLINSON%2C+A&rft.date=1997&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=1040-5488&rft.volume=74&rft.issue=1&rft.spage=8&rft.epage=13&rft_id=info:doi/10.1097%2F00006324-199701000-00014&rft.externalDBID=n%2Fa&rft.externalDocID=2613866
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1040-5488&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1040-5488&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1040-5488&client=summon